The relative contribution of metabolic and structural abnormalities to diastolic dysfunction in obesity

<strong>Background:</strong> Obesity causes diastolic dysfunction, and is one of the leading causes of heart failure with preserved ejection fraction. Myocardial relaxation is determined by both active metabolic processes such as impaired energetic status and steatosis, as well as intrin...

Full description

Bibliographic Details
Main Authors: Rayner, J, Banerjee, R, Holloway, C, Lewis, A, Peterzan, M, Francis, J, Neubauer, S, Rider, O
Format: Journal article
Published: Springer Nature 2017
_version_ 1797080625998462976
author Rayner, J
Banerjee, R
Holloway, C
Lewis, A
Peterzan, M
Francis, J
Neubauer, S
Rider, O
author_facet Rayner, J
Banerjee, R
Holloway, C
Lewis, A
Peterzan, M
Francis, J
Neubauer, S
Rider, O
author_sort Rayner, J
collection OXFORD
description <strong>Background:</strong> Obesity causes diastolic dysfunction, and is one of the leading causes of heart failure with preserved ejection fraction. Myocardial relaxation is determined by both active metabolic processes such as impaired energetic status and steatosis, as well as intrinsic myocardial remodelling. However, the relative contribution of each to diastolic dysfunction in obesity is currently unknown. <strong>Methods:</strong> Eighty adult subjects (48 male) with no cardiovascular risk factors across a wide range of body mass indices (18.4–53.0 kg m−2) underwent magnetic resonance imaging for abdominal visceral fat, left ventricular geometry (LV mass:volume ratio) and diastolic function (peak diastolic strain rate), and magnetic resonance spectroscopy for PCr/ATP and myocardial triglyceride content. <strong>Results:</strong> Increasing visceral obesity was related to diastolic dysfunction (peak diastolic strain rate, r=−0.46, P=0.001). Myocardial triglyceride content (β=−0.2, P=0.008), PCr/ATP (β=−0.22, P=0.04) and LV mass:volume ratio (β=−0.61, P=0.04) all independently predicted peak diastolic strain rate (model R2 0.36, P&lt;0.001). Moderated multiple regression confirmed the full mediating roles of PCr/ATP, myocardial triglyceride content and LV mass:volume ratio in the relationship between visceral fat and peak diastolic strain rate. Of the negative effect of visceral fat on diastolic function, 40% was explained by increased myocardial triglycerides, 39% by reduced PCr/ATP and 21% by LV concentric remodelling. <strong>Conclusions:</strong> Myocardial energetics and steatosis are more important in determining LV diastolic function than concentric hypertrophy, accounting for more of the negative effect of obesity on diastolic function than LV geometric remodelling. Targeting these metabolic processes is an attractive strategy to treat diastolic dysfunction in obesity.
first_indexed 2024-03-07T01:02:45Z
format Journal article
id oxford-uuid:8a454650-f3d8-4a45-bb5d-2c98f93e709a
institution University of Oxford
last_indexed 2024-03-07T01:02:45Z
publishDate 2017
publisher Springer Nature
record_format dspace
spelling oxford-uuid:8a454650-f3d8-4a45-bb5d-2c98f93e709a2022-03-26T22:30:32ZThe relative contribution of metabolic and structural abnormalities to diastolic dysfunction in obesityJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:8a454650-f3d8-4a45-bb5d-2c98f93e709aSymplectic Elements at OxfordSpringer Nature2017Rayner, JBanerjee, RHolloway, CLewis, APeterzan, MFrancis, JNeubauer, SRider, O<strong>Background:</strong> Obesity causes diastolic dysfunction, and is one of the leading causes of heart failure with preserved ejection fraction. Myocardial relaxation is determined by both active metabolic processes such as impaired energetic status and steatosis, as well as intrinsic myocardial remodelling. However, the relative contribution of each to diastolic dysfunction in obesity is currently unknown. <strong>Methods:</strong> Eighty adult subjects (48 male) with no cardiovascular risk factors across a wide range of body mass indices (18.4–53.0 kg m−2) underwent magnetic resonance imaging for abdominal visceral fat, left ventricular geometry (LV mass:volume ratio) and diastolic function (peak diastolic strain rate), and magnetic resonance spectroscopy for PCr/ATP and myocardial triglyceride content. <strong>Results:</strong> Increasing visceral obesity was related to diastolic dysfunction (peak diastolic strain rate, r=−0.46, P=0.001). Myocardial triglyceride content (β=−0.2, P=0.008), PCr/ATP (β=−0.22, P=0.04) and LV mass:volume ratio (β=−0.61, P=0.04) all independently predicted peak diastolic strain rate (model R2 0.36, P&lt;0.001). Moderated multiple regression confirmed the full mediating roles of PCr/ATP, myocardial triglyceride content and LV mass:volume ratio in the relationship between visceral fat and peak diastolic strain rate. Of the negative effect of visceral fat on diastolic function, 40% was explained by increased myocardial triglycerides, 39% by reduced PCr/ATP and 21% by LV concentric remodelling. <strong>Conclusions:</strong> Myocardial energetics and steatosis are more important in determining LV diastolic function than concentric hypertrophy, accounting for more of the negative effect of obesity on diastolic function than LV geometric remodelling. Targeting these metabolic processes is an attractive strategy to treat diastolic dysfunction in obesity.
spellingShingle Rayner, J
Banerjee, R
Holloway, C
Lewis, A
Peterzan, M
Francis, J
Neubauer, S
Rider, O
The relative contribution of metabolic and structural abnormalities to diastolic dysfunction in obesity
title The relative contribution of metabolic and structural abnormalities to diastolic dysfunction in obesity
title_full The relative contribution of metabolic and structural abnormalities to diastolic dysfunction in obesity
title_fullStr The relative contribution of metabolic and structural abnormalities to diastolic dysfunction in obesity
title_full_unstemmed The relative contribution of metabolic and structural abnormalities to diastolic dysfunction in obesity
title_short The relative contribution of metabolic and structural abnormalities to diastolic dysfunction in obesity
title_sort relative contribution of metabolic and structural abnormalities to diastolic dysfunction in obesity
work_keys_str_mv AT raynerj therelativecontributionofmetabolicandstructuralabnormalitiestodiastolicdysfunctioninobesity
AT banerjeer therelativecontributionofmetabolicandstructuralabnormalitiestodiastolicdysfunctioninobesity
AT hollowayc therelativecontributionofmetabolicandstructuralabnormalitiestodiastolicdysfunctioninobesity
AT lewisa therelativecontributionofmetabolicandstructuralabnormalitiestodiastolicdysfunctioninobesity
AT peterzanm therelativecontributionofmetabolicandstructuralabnormalitiestodiastolicdysfunctioninobesity
AT francisj therelativecontributionofmetabolicandstructuralabnormalitiestodiastolicdysfunctioninobesity
AT neubauers therelativecontributionofmetabolicandstructuralabnormalitiestodiastolicdysfunctioninobesity
AT ridero therelativecontributionofmetabolicandstructuralabnormalitiestodiastolicdysfunctioninobesity
AT raynerj relativecontributionofmetabolicandstructuralabnormalitiestodiastolicdysfunctioninobesity
AT banerjeer relativecontributionofmetabolicandstructuralabnormalitiestodiastolicdysfunctioninobesity
AT hollowayc relativecontributionofmetabolicandstructuralabnormalitiestodiastolicdysfunctioninobesity
AT lewisa relativecontributionofmetabolicandstructuralabnormalitiestodiastolicdysfunctioninobesity
AT peterzanm relativecontributionofmetabolicandstructuralabnormalitiestodiastolicdysfunctioninobesity
AT francisj relativecontributionofmetabolicandstructuralabnormalitiestodiastolicdysfunctioninobesity
AT neubauers relativecontributionofmetabolicandstructuralabnormalitiestodiastolicdysfunctioninobesity
AT ridero relativecontributionofmetabolicandstructuralabnormalitiestodiastolicdysfunctioninobesity